LOGIN
Comparison of efficacy between Artz and Durolane HAs at 18 and 26 weeks in treatment of knee OA
July 2019
Comparison of efficacy between Artz and Durolane HAs at 18 and 26 weeks in treatment of knee OA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE) study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz
Arthritis Res Ther. 2015 Mar 10;17:51. doi: 10.1186/s13075-015-0557-xDid you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
349 patients with knee osteoarthritis were randomized to either one intraarticular injection of Durolane hyaluronic acid followed by four weekly subcutaneous sham injections, or five weekly intraarticular injections of Artz hyaluronic acid. Patients were assessed for primarily for response on the Western Ontario and McMaster Universities Osteoarthritis Index to determine if Durolane was noninferio...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.